Diadema Partners »

Royalty Pharma shares owned by Diadema Partners

Quarter-by-quarter ownership of Royalty Pharma (RPRX) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Royalty Pharma

Tip: Access up to 7 years of quarterly data

All positions including Royalty Pharma held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Royalty Pharma by Diadema Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $5.6M 100k 56.07

More positions owned by Diadema Partners

Abivax Sa Sponsored Ads Call Option (ABVX)
Viking Therapeutics (VKTX)
Bristol Myers Squibb Put Option (BMY)
Amgen Call Option (AMGN)
United Therapeutics Corporation (UTHR)
Revolution Medicines (RVMD)
Uniqure Nv SHS Put Option (QURE)
Novartis Sponsored Adr Call Option (NVS)
Kodiak Sciences Call Option (KOD)
Capricor Therapeutics Com New Put Option (CAPR)
Cogent Biosciences (COGT)
Bridgebio Pharma Note 1.750% 3/0 (Principal)
Corcept Therapeutics Incorporated Call Option (CORT)
BioMarin Pharmaceutical (BMRN)
Kymera Therapeutics Call Option (KYMR)

View all positions for Diadema Partners

Top funds holding Royalty Pharma

Morgan Stanley
Capital Research and Management Company - Division 3
BlackRock
FMR
State Street Corporation
Swedbank AB
Baillie Gifford & Co
Geode Capital Management
Capital World Investors
Caledonia
Norges Bank Investment Management
Vanguard Capital Management
Northern Trust
Royal London Asset Management
AQR Capital Management

View all funds holding Royalty Pharma